US 11,730,713 B2
Composition for preventing or improving nociceptive pain
Yasuyo Suga, Kawasaki (JP); Ikuko Sasahara, Kawasaki (JP); Masaki Hashimoto, Tokyo (JP); Tomoyuki Mine, Tokyo (JP); Michihiro Takada, Kawasaki (JP); Makoto Ishii, Kawasaki (JP); and Michiya Kanzaki, Tokyo (JP)
Assigned to AJINOMOTO CO., INC., Tokyo (JP)
Filed by AJINOMOTO CO., INC., Tokyo (JP)
Filed on Jul. 23, 2020, as Appl. No. 16/936,799.
Application 16/936,799 is a continuation of application No. PCT/JP2019/002387, filed on Jan. 25, 2019.
Claims priority of application No. 2018-011964 (JP), filed on Jan. 26, 2018.
Prior Publication US 2020/0345677 A1, Nov. 5, 2020
Int. Cl. A61K 31/202 (2006.01); A23L 33/12 (2016.01); A23L 33/175 (2016.01); A61P 25/04 (2006.01); A61K 9/00 (2006.01); A61K 31/198 (2006.01)
CPC A61K 31/202 (2013.01) [A23L 33/12 (2016.08); A23L 33/175 (2016.08); A61K 9/0056 (2013.01); A61K 31/198 (2013.01); A61P 25/04 (2018.01); A23V 2002/00 (2013.01)] 5 Claims
 
1. A method for treating chronic nociceptive pain in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising one or more amino acids and one or more n-3 fatty acids, wherein the one or more amino acids comprises serine in an amount that is at least 50 wt % relative to the total amount of amino acid, and the one or more n-3 fatty acids comprises eicosapentaenoic acid in an amount that is at least 20 wt % relative to the total amount of n3 fatty acid.